| Entry |
|
| Symbol |
PDE6B
|
| Name |
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta [EC: 3.1.4.35]
|
| Pathway |
|
| Reaction |
| R01234 | guanosine 3',5'-cyclic phosphate 5'-nucleotidohydrolase |
|
| Disease |
| H00787 | Congenital stationary night blindness |
|
| Brite |
KEGG Orthology (KO) [BR:ko00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
K13756 PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
09150 Organismal Systems
09157 Sensory system
04744 Phototransduction
K13756 PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
Enzymes [BR:ko01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.35 3',5'-cyclic-GMP phosphodiesterase
K13756 PDE6B; rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta
|
| Other DBs |
|
| Genes |
» show all
|
| Reference |
|
| Authors |
Omori K, Kotera J |
| Title |
Overview of PDEs and their regulation. |
| Journal |
|
| Sequence |
|
| Reference |
|
| Authors |
Lugnier C |
| Title |
Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. |
| Journal |
|
| LinkDB |
|